Gregory J. Flesher serves as Executive at Novus Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Gregory J. Flesher has executed 7 insider transactions totaling $681.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 10, 2021 involved receiving (via award) 100,000 shares valued at $0.
Gregory J. Flesher currently holds 109,600 shares of Novus Therapeutics, Inc. (NVUS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory J. Flesher has been a net buyer of NVUS stock. They have purchased $653.0K and sold $28.5K worth of shares.
Gregory J. Flesher's most recent insider trade was on Dec 10, 2021, when they sold 100,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $8.00 |
| Discretionary |
| May 21, 2019 | NVUS | $5.6K | Sale | 2,937 | $1.91 | Discretionary |
| May 20, 2019 | NVUS | $22.9K | Sale | 11,701 | $1.96 | Discretionary |
| Mar 14, 2019 | NVUS | $0 | Award | 25,000 | $N/A | Discretionary |
| Mar 13, 2018 | NVUS | $0 | Award | 30,700 | $N/A | Discretionary |
| May 10, 2017 | NVUS | $589.0K | Purchase | 58,959 | $9.99 | Discretionary |